Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Single-Center Cross-Sectional Observational Study
IntroductionAccessibility of treatment with monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) signaling pathway is impeded by regulatory restrictions. Affected individuals may seek out other services including non-pharmacological therapies. Thus, we found it timely to ascert...
Main Authors: | Lucas Rundblad, Christopher Kjaer Cullum, Simona Sacco, Raquel Gil-Gouveia, Derya Uludüz, Thien Phu Do, Faisal Mohammad Amin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Pain Research |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpain.2022.935183/full |
Similar Items
-
A Systematic Review of Musculoskeletal Mobilization and Manipulation Techniques Used in Veterinary Medicine
by: Kevin K. Haussler, et al.
Published: (2021-09-01) -
Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study
by: Christopher Kjaer Cullum, et al.
Published: (2023-08-01) -
Impact of the COVID-19 Pandemic on Manual Therapy Service Utilization within the Australian Private Healthcare Setting
by: Reidar P. Lystad, et al.
Published: (2020-12-01) -
Fascial neuromodulation: an emerging concept linking acupuncture, fasciology, osteopathy and neuroscience
by: Gianluca Bianco
Published: (2019-08-01) -
Information Survey on the Use of Complementary and Alternative Medicine
by: Marco Paoloni, et al.
Published: (2022-01-01)